These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8015704)
1. [Treatment with GnRH analogs in polycystic ovarian disease. A collaborative multicenter study. The preliminary results]. Cipolla L; Zagni R; Ferrante B; Giannetta G; Soliani A Minerva Ginecol; 1994 Mar; 46(3):85-9. PubMed ID: 8015704 [TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass. Lupoli G; Di Carlo C; Nuzzo V; Vitale G; Russo D; Palomba S; Nappi C J Endocrinol Invest; 1997 Sep; 20(8):493-6. PubMed ID: 9364254 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. Zacchè MM; Caputo L; Filippis S; Zacchè G; Dindelli M; Ferrari A Gynecol Endocrinol; 2009 Aug; 25(8):508-13. PubMed ID: 19551544 [TBL] [Abstract][Full Text] [Related]
4. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne. Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496 [TBL] [Abstract][Full Text] [Related]
5. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization? Orvieto R; Meltcer S; Homburg R; Nahum R; Rabinson J; Ashkenazi J Fertil Steril; 2009 Apr; 91(4 Suppl):1466-8. PubMed ID: 18774558 [TBL] [Abstract][Full Text] [Related]
6. Ovarian hyperstimulation after administration of triptorelin therapy to a patient with polycystic ovary syndrome. Campo S; Bezzi I; Garcea N Fertil Steril; 2000 Jun; 73(6):1256-8. PubMed ID: 10856495 [No Abstract] [Full Text] [Related]
7. [Polycystic ovary. The PCO syndrome]. Goldenstein S; Sillem M Med Monatsschr Pharm; 2002 Jul; 25(7):233-5. PubMed ID: 12148236 [No Abstract] [Full Text] [Related]
8. Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran. Hashemipour M; Faghihimani S; Zolfaghary B; Hovsepian S; Ahmadi F; Haghighi S Horm Res; 2004; 62(6):278-82. PubMed ID: 15523185 [TBL] [Abstract][Full Text] [Related]
9. Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism. Carmina E; Janni A; Lobo RA J Clin Endocrinol Metab; 1994 Jan; 78(1):126-30. PubMed ID: 8288696 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic treatment of polycystic ovary syndrome. Ehrmann DA; Rychlik D Semin Reprod Med; 2003 Aug; 21(3):277-83. PubMed ID: 14593550 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome. Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591 [TBL] [Abstract][Full Text] [Related]
12. Hormonal therapy for acne: why not as first line therapy? facts and controversies. Katsambas AD; Dessinioti C Clin Dermatol; 2010; 28(1):17-23. PubMed ID: 20082945 [TBL] [Abstract][Full Text] [Related]